John F. Paolini
2019
In 2019, John F. Paolini earned a total compensation of $1.5M as Senior Vice President and Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd., a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,577 |
|---|---|
| Option Awards | $923,363 |
| Salary | $443,100 |
| Other | $11,200 |
| Total | $1,517,240 |
Paolini received $923.4K in option awards, accounting for 61% of the total pay in 2019.
Paolini also received $139.6K in non-equity incentive plan, $443.1K in salary and $11.2K in other compensation.
Rankings
In 2019, John F. Paolini's compensation ranked 7,263rd out of 13,971 executives tracked by ExecPay. In other words, Paolini earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,263 out of 13,971 | 48th |
Division Manufacturing | 2,797 out of 5,701 | 51st |
Major group Chemicals And Allied Products | 1,042 out of 2,200 | 53rd |
Industry group Drugs | 886 out of 1,886 | 53rd |
Industry Pharmaceutical Preparations | 657 out of 1,398 | 53rd |
Source: SEC filing on April 28, 2020.
Paolini's colleagues
We found three more compensation records of executives who worked with John F. Paolini at Kiniksa Pharmaceuticals, Ltd. in 2019.